Trials / Completed
CompletedNCT02714244
Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.
Evaluation of the E/e' Ratio of the Mitral Annulus Measured by Transesophageal Echocardiography in Predicting Fluid Responsiveness.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Montreal Heart Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Diastolic function may be evaluated by different measurements on transesophageal echocardiography (TEE). They include mitral inflow velocities obtained by pulsed-wave doppler (PW) : peak early diastolic velocity (E) and late diastolic velocity (A). Mitral annulus velocities, early diastolic (e') and late diastolic (a') are obtained by tissue doppler imaging (TDI). The ratio E/e' reflects left ventricular filling pressure and, as such, might be a predictor of fluid responsiveness. The aim of this study is to evaluate the predictive value of the mitral valve E/e' ratio for fluid responsiveness among patients undergoing coronary bypass graft surgery. Fluid responsiveness being defined as an increase in stroke volume of ≥ 15%. After induction of anesthesia, patients will have their diastolic function evaluated by means of E/e' and other measures. They will then be administered an intravenous bolus of 500 mL of Lactate Ringer® along with passive leg raising (PLR). Stroke volume and fluid responsiveness will be assessed by the thermodilution method (Swan-Ganz catheter) and the FloTrac® device. Fluid responders will be compared to non-responders to evaluate the relationship between E/e' ratio and fluid responsiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Volume expansion | Volume expansion with rapid administration of 500 ml of crystalloid |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-03-21
- Last updated
- 2017-09-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02714244. Inclusion in this directory is not an endorsement.